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ABSTRACT 
 
Dr.Bharathi Raja. G MD, General Medicine, Coimbatore Medical College 
Hospital , Coimbatore.  
 
Title:    A Dissertation on A Study of Drug Resistance TB among patients with 
New Sputum Smear Positive Pulmonary Tuberculosis  
 
Setting :  
         100 number  patients of patients with New Smear Positive Pulmonary 
Tuberculosis in Coimbatore Medical College Hospital, Coimbatore. 
Objective:  
To determine drug resistance in new smear positive pulmonary tuberculosis. 
Design:  
   Cross sectional study done from July 2014 to June 2015, All 100, new 
smear positive pulmonary tuberculosis patients screened for Rifampicin resistance 
by using GENE XPERT/RIF assay 
Results: 
 A total of 100 , new smear positive pulmonary tuberculosis  patients were 
included in this study. There were Rifampicin resistance were found about 2% of 
these patients. 
       
    Conclusion:  
Rifampicin  resistance is the main indictor of MDR TB because the 
resistance to RIF mostly combined with the resistance for Isoniazid. Since, this is 
the indicator for prevalence of MDR-TB and all new smear positive patients 
should be screened for the same to early detection, prevention of spread and 
management of MDR-TB. 
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